Ticker Scorecard - BBIO Basics Company: BridgeBio Pharma, Inc. IPO Date: June 24, 2019 Sector: Healthcare Industry: Biotech Market Cap: $6.96B Activated in VL: True Average Daily Range Avg Daily Range: $0.85 | 3.17% Avg Daily Range (30 D): $1.19 | 3.59% Avg Daily Range (90 D): $0.78 | 2.68% Institutional Daily Volume Avg Daily Volume: 1.35M Avg Daily Volume (30 D): 2.63M Avg Daily Volume (90 D): 1.93M Trade Size Avg Trade Size (Sh.): 88 Avg Trade Size (Sh.) (30 D): 85 Avg Trade Size (Sh.) (90 D): 78 Institutional Trades Total Inst.Trades: 5,240 Avg Inst. Trade: $2.85M Avg Inst. Trade (30 D): $2.77M Avg Inst. Trade (90 D): $2.83M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.86M Avg Closing Trade (30 D): $11.72M Avg Closing Trade (90 D): $9.04M Avg Closing Volume: 233.65K     News Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight Nov 23, 2024 @ 12:11 AM Attrubyâ„¢ (acoramidis), a Near Complete TTR S... Source: Bridgebio Pharma, Inc. Sep 11, 2024 @ 5:44 PM BridgeBio Pharma Seeks Partner To Develop Gene The... Source: Vandana Singh Aug 30, 2024 @ 2:50 PM BridgeBio Shares Data on Serum TTR Increase When S... Source: N/A Jul 5, 2024 @ 8:33 PM BridgeBio Pharma Reports Inducement Grants under N... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-2.88 $-1.42 $-2.88 Diluted EPS $-2.88 $-1.42 $-2.88 Revenue $ 221.9M $ 5.88M $ 221.9M Gross Profit $ 218.02M $ 3.8M $ 218.02M Net Income / Loss $ -543.35M $ -267.39M $ -543.35M Operating Income / Loss $ -592.97M $ -226.03M $ -592.97M Cost of Revenue $ 3.88M $ 2.08M $ 3.88M Net Cash Flow $ 288.51M $ 275.37M $ 288.51M PE Ratio